A novel form of light chain gene replacement
轻链基因替换的新形式
基本信息
- 批准号:10191435
- 负责人:
- 金额:$ 21.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-19 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAllelesAntibodiesAntibody FormationAntigen ReceptorsB cell repertoireB-LymphocytesBase SequenceBindingCategoriesCellsChimera organismCleaved cellCodeDNADataDependenceDevelopmentEphrin-A5EpitopesEventExonsExploratory/Developmental GrantFoundationsFramework RegionsFrequenciesGene ConversionGene RearrangementGenerationsGenesGenetic RecombinationGenomic InstabilityHeavy-Chain ImmunoglobulinsHybridomasHybridsImmuneImmunityImmunoglobulin Somatic HypermutationImmunoglobulinsImpairmentIn VitroIndividualKnock-inLeadLecithinLightLiposomesLymphocyteMalignant NeoplasmsMediatingModelingMusMutationNonhomologous DNA End JoiningOrganismPathogenicityPeptide Signal SequencesPopulation HeterogeneityProcessProteinsReceptor GeneRecombinant AntibodyRecurrenceReportingResearchSequence AnalysisSiteStructureSurface AntigensT-LymphocyteTestingTherapeutic antibodiesTransgenic MiceWorkactivation-induced cytidine deaminaseadaptive immunitybasechimeric genedesignevidence basegene replacementgenomic locushigh rewardhigh riskimmunoreactivityinsightkappa-Chain Immunoglobulinsmicrobialmicroorganismnovelprogramsreceptorrepairedsingle cell sequencing
项目摘要
PROJECT SUMMARY
B and T lymphocytes form the foundation of our adaptive immune system, which is based on specific
recognition of foreign molecules by structurally diverse surface antigen receptors. Structural diversity in these
receptors originates through site-specific rearrangement of antigen receptor genes during lymphocyte
development. This rearrangement process, called V(D)J recombination, is initiated when the RAG1/2 proteins
cleave antigen receptor gene segments at recombination signal sequences (RSS) through a nick-hairpin
mechanism, and is completed when the DNA breaks are sensed and repaired by non-homologous end-joining.
Classically, B cell repertoire diversity is considered restricted by the number of functional V, D, and J gene
segments in the immunoglobulin (Ig) heavy and light chain gene loci. However, forms of secondary V(D)J
rearrangement have been reported in which an unrearranged Ig heavy chain V (VH) gene segment replaces a
rearranged VH gene via recombination with a cryptic RSS embedded in the 3’ end of the VH gene (called VH
gene replacement). Mechanistic insight into this process has been hampered by the low frequency of these
events and, typically, the use of germline pre-rearranged VH alleles. Whether similar events occur in the light
chain loci remains unclear. We recently performed bulk light chain repertoire sequencing of B cells from
transgenic mice expressing the Ig VH12 heavy chain, sorted based on immunoreactivity to
phosphatidylcholine. Interestingly, our analysis uncovered infrequent, but recurrent, endogenous hybrid
rearranged Ig kappa V (KV) gene sequences, in which the 3’ end of the highly selected KV4-91 gene was
replaced by another KV gene. Based on this preliminary data, our working hypothesis is that the RAG proteins
mediate KV gene replacement in VH12 mice via cleavage of a cryptic RSS identified in framework region 3 of
the KV gene (KV FR3 cRSS). The proposed project will extend our preliminary findings to confirm KV gene
replacement leads to productive antibody generation in single B cells, test whether the KV FR3 cRSS supports
RAG-mediated cleavage and rearrangement in vitro and in cells, and also exclude activation-induced cytidine
deaminase (AID) as an alternative mechanism for KV gene replacement in VH12 mice. This project will
challenge our current understanding of the theoretical constraints on antibody structural diversity, and lead to
considering KV gene chimeras for rational design of therapeutic antibodies. This work will also highlight an
important potential caveat of automated KV sequence analysis, because such events (regardless of origin)
may be missed in KV gene calls or be mistaken for somatic hypermutation. The potential of this project to shift
existing paradigms places the project in the “high risk-high reward” category for which the R21 was designed.
项目摘要
B和T淋巴细胞构成了我们自适应免疫系统的基础,该系统基于特定
在这些结构抗原受体上识别外国分子。
受体来自淋巴细胞期间特定的抗原重排
开发。
在重组信号序列(RSS)上切割抗原受体基因片段通过尼克·希尔平
当DNA断裂通过非同源末端连接来感知和修复时,机理被构成。
从经典上讲,B细胞库的多样性被功能V,D和J基因的数量限制。
免疫球蛋白(IG)中的片段重链基因基因座。
已经报道了重排,其中透明的Ig重链V(VH)基因段取代了
通过重组与嵌入在VH基因的3'端中的隐性RSS重组(称为VH)通过重新组合(称为VH)
基因替代)对此过程的洞察力受到了低频
事件,通常是使用种系预先恢复的VH Allels的事件。
链基因座尚不清楚。
表达IG VH12重链的转基因小鼠,基于免疫反应性排序
磷脂酰胆碱。
重排IG Kappa V(KV)基因序列,其中高度选择的KV4-91基因的3'端为
取代了另一个KV基因。
通过在框架区域3中鉴定的密码RSS的裂解3
KV基因(KV FR3 CRS)。
替换会导致单个B细胞的生产抗体产生,测试KV FR3 CRSS是否支持
抹布介导的裂解和体外和细胞重排,也排除了激活诱导的胞苷
脱氨酶(AID)作为VH12小鼠的KV基因替代的替代机制。
挑战我们当前对理论约束Ontibopy结构多样性的理解,并领导
考虑KV基因嵌合体进行治疗抗体的合理设计。
自动化KV序列分析的重要潜在警告,因为此类事件(无论起源如何)
可能会错过KV基因呼叫,也可以误认为该项目的可能性。
现有的范式将该项目列入了R21设计的“高风险高奖励”类别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick C. Swanson其他文献
Patrick C. Swanson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick C. Swanson', 18)}}的其他基金
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10430247 - 财政年份:2021
- 资助金额:
$ 21.83万 - 项目类别:
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10302865 - 财政年份:2021
- 资助金额:
$ 21.83万 - 项目类别:
DCAF1(VprBP) regulates FoxO1 to promote Rag transcription
DCAF1(VprBP)调控FoxO1促进Rag转录
- 批准号:
9808408 - 财政年份:2019
- 资助金额:
$ 21.83万 - 项目类别:
Implications of B10-like cell expansion in a model of impaired receptor editing
B10 样细胞扩增对受体编辑受损模型的影响
- 批准号:
9244625 - 财政年份:2016
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8876720 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8499380 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8688270 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8345107 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Defining the role of a novel E3 ubiquitin ligase in V(D)J recombination
定义新型 E3 泛素连接酶在 V(D)J 重组中的作用
- 批准号:
8313160 - 财政年份:2011
- 资助金额:
$ 21.83万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Intravitreal gene therapy for inherited retinal disease
遗传性视网膜疾病的玻璃体内基因治疗
- 批准号:
10660784 - 财政年份:2023
- 资助金额:
$ 21.83万 - 项目类别:
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
针对分子定义的难治性黑色素瘤子集的新型细胞治疗方法
- 批准号:
10780289 - 财政年份:2023
- 资助金额:
$ 21.83万 - 项目类别:
Computational Methods for Analyzing lmmunoglobulin Allelic Diversity in B cells
分析 B 细胞中免疫球蛋白等位基因多样性的计算方法
- 批准号:
10751541 - 财政年份:2023
- 资助金额:
$ 21.83万 - 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
- 批准号:
10543560 - 财政年份:2022
- 资助金额:
$ 21.83万 - 项目类别: